Wednesday, May 08, 2013 9:36:17 AM
noteworthy from Dr. H's email on expectations:
First, the program is still early stage. Only in late January did DLA announce that the agency would subsidize SigNature DNA marking costs for its trusted suppliers, and only in March, after this and other mechanisms were in place, was our company able to begin SigNature DNA shipments. We are not close to the potential for this program.
First, the program is still early stage. Only in late January did DLA announce that the agency would subsidize SigNature DNA marking costs for its trusted suppliers, and only in March, after this and other mechanisms were in place, was our company able to begin SigNature DNA shipments. We are not close to the potential for this program.
Recent BNBX News
- BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing • Business Wire • 05/26/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:21:22 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 12:30:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 08:10:24 PM
- BNB Plus Corp. Completes Historic $1.2 Million LineaDNA™ Order • Business Wire • 04/23/2026 11:00:00 AM
- BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value • Business Wire • 04/20/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:09:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:08:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:07:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/24/2026 08:15:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:06:00 PM
- BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform • Business Wire • 03/18/2026 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/12/2026 09:24:23 PM
- BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers • Business Wire • 02/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:16:58 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/13/2026 07:49:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 09:32:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:11:07 PM
- BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director • Business Wire • 02/05/2026 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/30/2026 09:06:16 PM
- Digital Asset Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 01/28/2026 01:35:00 PM

